Introduction
The rising prevalence of multidrug-resistant bacteria has emerged as one of the greatest challenges to quality healthcare delivery with a greater burden on developing nations, accounting for a large proportion of hospital-acquired infections. 1, 2 Bacterial infections are commonly treated by β-lactam antibiotics and a major mechanism of resistance to this class of antibacterial drugs is the production of β-lactamase. 1 β-Lactamases inactivate penicillins, cephalosporins, monobactams, and carbapenems by hydrolyzing the amide bond of the β-lactam ring. 3 Enterobacteriaceae and oxidase positive gram-negative rods have gained notoriety for resistance to β-lactam drugs by producing β-lactamase enzymes, namely extended spectrum β-actamase (ESBL), AmpC beta-lactamases and carbapenemases against these drugs. [1] [2] [3] ESBLs are enzymes capable of cleaving third-generation cephalosporins (ceftriaxone, ceftazidime, cefotaxime) and aztreonam. 4 The most prevalent enzymes among them are the TEM, SHV, CTX-M and OXA variants, with the genetic determinants being largely borne on transmissible plasmids and are capable of horizontal transfer between species. 4 ESBLs are inhibited by clavulanic acid and have been closely associated with resistance to other classes of antibacterials. 5 Such organisms producing these enzymes become multi-drug resistant leading to limited therapeutic options for infections.
AmpC β-lactamases are cephalosporinases and are poorly inhibited by clavulanic acid. They differ from ESBLs by their ability to hydrolyze and inactivate cephalosporins (e.g. ceftriaxone, cefotaxime, and ceftazidime), cephamycins (e.g. cefoxitin and cefotetan), aminopenicillins and monobactams. 1 The enzyme has been shown to have chromosomal and plasmid-mediated mechanisms of resistance. 1 Carbapenem antibiotics (e.g imipenem, ertapenem, meropenem) are used as a last resort to treat infections caused by multidrug resistant gram negative bacteria (GNB) and have shown remarkable activity against ESBL and AmpC producing bacteria. 2, 6 However, as a result of selective pressure which enhances antibacterial resistance, carbapenemase enzymes emerged among GNB and had the capacity to inactivate the carbapenems and other beta-lactam agents. 2, 7 The most common carbapenemase enzymes include Klebsiella pneumoniae carbapenemase (KPC), verona integron metallo-beta-lactamases types (VIM), oxacillinase-48 (OXA-48), New Delhi metallobeta-lactamase-1 (NDM-1) and imipenemase (IMP) types. 2, 8 In Nigeria, indiscriminate use of antibiotics, poor hygienic practices in hospitals and lack of monitoring of microbial drug resistance may have exerted selective pressure, leading to the emergence of ESBLs, AmpC and recently MBL enzymes. 7, 9 Indeed, these enzymes have demonstrated varying prevalence rates in southeastern and north-western Nigeria. 3, 6 Paucity of data on the prevalence of AmpC β-lactamase and metallo-β-lactamase (MBL) in South-South Nigeria coupled with the fact that no previous study in our environment had looked for these three enzymes simultaneously necessitated this study. This study aimed at determining the prevalence, distribution and antibiotic susceptibility of ESBL, AmpC and MBL-producing GNB recovered from clinical specimens in a tertiary hospital in Southern Nigeria.
Materials and Methods

Bacterial Isolates
For this study, 309 consecutive non-repetitive bacterial isolates were recovered from clinical specimens, namely ear swab, eye swab, throat swab, vaginal swabs, wound swab, catheter tip, sputum, stool, urine and aspirates. These specimens were processed in the Medical Microbiology Laboratory, Medical Laboratory Services of University of Benin Teaching Hospital (UBTH) between February 3, 2016 and May 2, 2016. UBTH is a tertiary hospital with 700 beds and 20 wards, serving the specialist healthcare needs of Edo State and 6 to 10 other neighboring States. A total of 187 bacterial isolates were recovered from inpatients while 122 bacterial isolates were recovered from outpatients. Bacterial isolates were identified using standard techniques. 10 
ESBL Detection
All gram negative bacilli isolates were screened for ESBL. ESBL was detected using the double disc diffusion test as previously described.
11 ESBL positive K. pneumonia ATCC 700603 was included.
Test for Plasmid AmpC β-Lactamase
The cefoxitin-cloxacillin inhibition test was performed as previously described. 12 Briefly, the test isolates were seeded on Mueller-Hinton agar (MHA) and two 30 µg cefoxitin discs (Abtek Biologicals Ltd., Liverpool, U.K) were placed on the surface of the seeded MHA plate. One of the cefoxitin discs was supplemented with 200 µg cloxacillin. The plate was incubated at 37 º C overnight. The zone diameter was measured and AmpC β-lactamase was inferred if the zone of the cefoxitin disc supplemented with cloxacillin was ≥4 mm greater than that of cefoxitin alone.
Tests for Inducibility of Chromosomal β-Lactamases (AmpC β-Lactamases) Chromosomal AmpC was detected using a modification of the previously described method. 11 Briefly, MHA plates were inoculated with test organisms for ESBL detection. A 30 µg ceftazidime and ceftriaxone discs was placed 25 mm apart from cefoxitin 30 µg discs with cefoxitin disc at their center. The plates were incubated at 37 º C overnight. Inducible AmpC β-lactamase was inferred if blunting was observed in the ceftazidime and/or ceftriaxone zone of inhibition adjacent to the cefoxitin disc. A previously known positive Pseudomonas aeruginosa isolate and a negative control strain (Escherichia coli ATCC 25922) were included in this experiment.
Metallo-β-Lactamase Detection
A modification of the method described by Lee et al was used for the detection of MBL. 13 Briefly, each gramnegative bacillus was seeded on the surface of MHA plate for ESBL detection. Imipenem and meropenem discs (10 µg each) were placed on either side of a 1900 µg ethylenediaminetetraacetic acid (EDTA) disc, 10 mm apart from the EDTA disc (edge-to-edge) on the seeded plate. The plate was incubated overnight at 37 º C. A synergistic zone of inhibition between the EDTA disc and one or both discs was taken as positive for metallo-β-lactamase when compared with the negative control strain E. coli ATCC 25922 which did not show any synergism.
Disc Susceptibility Test
Disc susceptibility tests were performed on all bacterial isolates using the British Standard for Antimicrobial Chemotherapy (BSAC) method. 14 
Data Analysis
The data obtained were analyzed using chi-square and odd ratio (OR) analysis using the statistical software INSTAT ® (Graph Pad Software Inc., La Jolla, CA, USA).
Results
The various isolates recovered and used in this study included Citrobacter species (9) (10), Pseudomonas aeruginosa (37) and Acinetobacter species (4). Among 309 bacterial isolates screened for ESBL, 129 (41.7%) were positive for the enzyme. Of the ESBL positive isolates, 116 (37.5%) were indicated by both cefotaxime and ceftazidime, 4 (1.3%) was detected by ceftazidime alone while 9 (2.9%) was indicated by cefotaxime alone. This difference was statistically significant (P < 0.0001). The rate of detection of AmpC β-lactamase by the cefoxitin-cloxacillin inhibition test was significantly higher compared with the rate of detection by blunting with ceftazidime, ceftriaxone or both (P < 0.0001). Similarly, the rate of detection of MBL was significantly higher with both imipenem and meropenem than either alone (P = 0.0003) ( Table 1) . ESBL was the most prevalent β-lactamase enzyme produced alone by bacterial isolates in this study and showed statistical significance (P < 0.0001). Production of 2 β-lactamase enzymes was observed in 21.4% with ESBL + MBL showing the highest while all 3 enzymes in combination were the least prevalent (Table 2) .
Among isolates that produced ESBL, AmpC β-lactamase and MBL, only ESBL was significantly associated (OR = 2.225, 95% CI = 1.375, 3.599; P = 0.0015) with isolates recovered from inpatients ( Table 3) .
The highest prevalence of ESBL, AmpC β-lactamase and MBL enzyme was observed among Providencia species (P = 0.0007), P. aeruginosa (P = 0.0206) and Citrobacter species (P < 0.0001) respectively (Table 4) .
Isolates recovered from urine were the highest producers of ESBL and MBL while isolates from the eye were the most predominant producers of AmpC β-lactamase (Table 5 ). However, type of specimen did not significantly affect the prevalence of ESBL, MBL and AmpC β-lactamase (P > 0.05).
The susceptibility profiles of β-lactamase producing and non-β-lactamase producing GNB isolates are shown in Tables 6 and 7 respectively. β-Lactamase positive isolates showed poor activity against cephalosporins, amoxicillinclavulanate, gentamicin and the fluoroquinolones in comparison with non-β-lactamase producers. Imipenem and meropenem were the most active antibiotics against β-lactamase and non-β-lactamase producing bacterial isolates.
Discussion
In the present study, ESBL was more likely to be detected by ceftazidime and cefotaxime antibiotic discs (P < 0.0001). The use of both antibiotics for phenotypic screening has been shown to be very reliable in detecting the presence of most ESBL genes; TEM, SHV and CTX-M types. 4 Previous studies have shown that the use of ceftazidime disc alone as an indicator cephalosporin in the disc diffusion method can result in false negative result as it poorly detects ESBL of the CTX-M type. 4 CTX-M gene has been shown to be the predominant ESBL producing gene in south-western Nigeria. 15 A combination of both discs is therefore recommended for ESBL detection. Also, plasmid-mediated AmpC production was more likely to be detected in this study than chromosomally-mediated AmpC production (P < 0.0001). Besides their capacity for transfer between species, plasmids carrying genes for AmpC β-lactamase often carry multiple other resistances including genes for resistance to chloramphenicol, aminoglycosides, quinolones, tetracycline, sulfonamide, and trimethoprim as well as genes for other β-lactamases such as TEM-1and PSE-1. 16 A combination of both techniques is however strongly recommended in order not to miss out on detection of the chromosomally mediated type, since their detection would mean treatment failure when cephalosporins, cephamycins and monobactams are administered. 6 MBL was also more likely to be detected Abbreviations: ESBL, extended spectrum β-lactamase; MBL, metallo-β-lactamase; AmpC, AmpC β-lactamase; CAZ, ceftazidime; CTX, cefotaxime; CRO, ceftriaxone; CXT, cefoxitin; IMP, imipenem; MEM, meropenem. ESBL: P < 0.0001, AmpC: P < 0.0001, MBL: P = 0.0003. Abbreviations: ESBL, extended spectrum β-lactamase; MBL, metallo-β-lactamase; AmpC, AmpC β-lactamase. β-Lactamase enzyme vs. isolates: P < 0.0001.
using a combination of imipenem and meropenem antibiotics (P = 0.0003).
There is yet no standardized phenotypic test for detecting MBL routinely. 17 We, therefore, advocate the use of a combination of imipenem and meropenem for MBL detection in our region as using single antibiotic disc may underestimate the true prevalence of MBL production.
ESBL was also the most prevalent β-lactamase enzyme in this study. Plasmids bearing the genes encoding ESBLs have been shown to also carry genes encoding resistance to aminoglycosides, quinolones and trimethoprim/ sulfamethoxazole. 4 .There is therefore the likelihood of therapeutic failure if these drugs are administered against ESBL positive isolates. Similarly, Production of 2 β-lactamase enzyme was demonstrated in 21.4% of bacterial isolates with ESBL + MBL having the highest prevalence. MBLs confer resistance to carbapenems and its production is typically associated with resistance to Abbreviations: ESBL, extended spectrum β-lactamase; MBL, metallo-β-lactamase; AmpC, AmpC β-lactamase; OR, odds ratio. aminoglycosides and fluoroquinolones. 3 The coexistence of ESBL and MBL enzymes in a bacterium therefore severely limits treatment options when implicated in infections. It is noteworthy to state that these enzymes are hardly screened for during routine antimicrobial susceptibility testing of clinical bacterial isolates in most healthcare facilities in Nigeria. Screening for ESBL, AmpC β-lactamase and MBL should therefore be an adjunct to routine antimicrobial susceptibility testing of GNB causing clinical infections in Nigeria as their detection markedly influences therapeutic options.
Bacterial isolates recovered from inpatients in this study were more likely to produce ESBL than outpatients. This finding is in contrast with another study in this facility which observed that the prevalence of ESBL did not differ significantly in GNB recovered from inpatients in comparison with out-patients. 9 It, however, aligns with another study. 18 A study in south-western Nigeria recovered 35% of ESBL producing strains from community dwellers while 65% were recovered from samples of inpatients. 18 In the study site, ceftriaxone and most β-lactam antibiotics are administered empirically, during emergencies and as antibiotic coverage during surgery. This may have over time exerted selective pressure, leading to the production of ESBL enzymes by opportunistic bacteria.
In this study, Providencia species showed the highest prevalence of ESBL. This finding is at variance with several Nigerian studies which showed Enterobacter species and Klebsiella species as the most prevalent ESBL producers, 9, 15 Enterobacter spp. was however not recovered from clinical samples during the period of this study. Novel genetic determinants of ESBL namely, VEB-1 and OXA-10 had been detected in Providencia species recovered from wound swabs and catheter tips in a previous study in Nigeria. 19 The study therefore shows that more attention should be accorded this bacterium as most strains were multidrug resistant. Also, P. aeruginosa was the most prevalent producer of AmpC β-lactamase enzymes with 35.1% prevalence. This finding agrees with a study in India in which P. aeruginosa ranked the highest among bacterial isolates producing AmpC β-lactamase with 33.3%, but is however in contrast with a Nigerian study which showed E. coli as the highest producer of the enzyme. 20, 21 Citrobacter species were the most prevalent producers of MBL (44.4%) and differs from previous studies. A study in Nigeria had shown E. coli (13.0%) and another study in Uganda showed a high prevalence of MBL genes (NDM-1, VIM and IMP) in K. pneumoniae compared with other GNB. 2, 3 There was no statistical significance between specimen type and β-lactamase enzyme produced by GNB recovered from them in this study. However, ESBL and MBL enzymes showed high prevalence in bacterial strains recovered from urine. Wound and urinary specimens form the largest group of clinical specimens received in microbiology laboratories as was the case in this study. 9 Our finding compares with previous studies which have shown that most GNB recovered from urine and wounds are ESBL-producing and another in which urine samples had the highest prevalence of MBL producing bacteria. 3, 9 The carbapenems (imipenem and meropenem) which were the most effective antibiotics in this study showed activity against ESBL and AmpC β-lactamase producing GNBs. The carbapenems are expensive drugs of last resort in our region and have shown good activity against GNB producing both enzymes. 2, 6, 9 Resistance was however observed to this class of β-lactam antibiotics as seen in some β-lactamase and non-β-lactamase producing strains. Similarly, the carbapenems, fluoroquinolones and cephalosporins were more effective against non-β-lactamase producers. This finding further accentuates the role of β-lactamase production in resistance to β-lactam and other classes of antibacterial drugs. The absence of β-lactamase enzymes from Acinetobacter species during the study period is noteworthy and isolates were sensitive to most antibiotics used, though strains of Acinetobacter species recovered from this facility showed ESBL positivity and marked resistance in previous study. 9 A comparatively lower number of isolates in this study may have played a role in the lower rate of detection of the enzyme.
Conclusion
A prevalence of 41.7%, 15.2% and 28.5% was observed for ESBL, AmpC β-lactamase and MBL respectively among GNB recovered from clinical samples in this study.
Isolates that produced either of these enzymes were more resistant to antibacterial agents. Prudent use of antibiotics in hospital and community settings is strongly advocated.
